Literature DB >> 12009273

Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors.

Chelsea M Byrd1, Tove' C Bolken, Kevin F Jones, Travis K Warren, Anthony T Vella, Jenny McDonald, David King, Zach Blackwood, Dennis E Hruby.   

Abstract

To test the effect of co-expression of immunomodulatory molecules, together with target antigen, two recombinant Streptococcus gordonii strains were constructed which secreted either murine interleukin-2 (IL-2) or interferon-gamma (IFN-gamma) in addition to a surface anchored test antigen (the conserved C-repeat region (CRR) of the M6 protein of Streptococcus pyogenes). The secretion of functional cytokines by S. gordonii was achieved by in-frame fusion of sequences encoding mature IL-2 or IFN-gamma to the sequences encoding the leader signal of the M6 protein. Expression of the M protein CRR region from a separate chromosomal site produced double recombinants expressing a secreted cytokine and the M protein CRR region anchored to the surface. Protein expression was verified by streak blot, immunoblot, and ELISA on both the single and double recombinants. A cytokine bioassay using HT-2 cells verified biological activity of recombinant IL-2 secreted from S. gordonii. When mice were immunized subcutaneously with the different S. gordonii expression strains, cytokine co-expression apparently modulated the systemic immune response. These results show that streptococci can deliver biologically active molecules such as cytokines along with antigens to the immune system. These results demonstrate that a cytokine-secreting, noninvasive, bacterial vaccine vector can be used to modulate immune responses to a co-expressed antigen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009273     DOI: 10.1016/s0264-410x(02)00144-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine.

Authors:  Karen L Kotloff; Steven S Wasserman; Kevin F Jones; Sofie Livio; Dennis E Hruby; Christine A Franke; Vincent A Fischetti
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 2.  Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorism.

Authors:  Rebecca L Wilson; Dennis E Hruby
Journal:  Adv Drug Deliv Rev       Date:  2005-04-14       Impact factor: 15.470

Review 3.  Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.

Authors:  Ivan Y C Lin; Thi Thu Hao Van; Peter M Smooker
Journal:  Vaccines (Basel)       Date:  2015-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.